PhRMA speaks out against FDA biosimilar flexibility
PhRMA has spoken out against FDA plans to allow biosimilar manufacturers flexibility in delivery device and formulation choice.
Archives for April 29, 2012
West raises outlook as client conservatism drives sales
West has raised its outlook for 2012 after a shift in supply chain attitude by clients drove strong first quarter sales.